Evidence map›Paper›PMID 18079404›Full record

ArticleScience (New York, N.Y.)2007

Transcribing RNA polymerase II is phosphorylated at CTD residue serine-7.

Rob D Chapman, Martin Heidemann, Thomas K Albert, Reinhard Mailhammer, Andrew Flatley, Michael Meisterernst, Elisabeth Kremmer, Dirk Eick

Abstract read
PubMed Publisher
In one paragraph

Article in Science (New York, N.Y.), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 201 papers.

0numbers the graph read from it
0cells of the map it votes in
201citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

201 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. CRL3Molecular cell · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer.Journal of experimental & clinical cancer research : CR · 2022
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

141 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Rob D ChapmanInstitute of Clinical Molecular Biology and Tumour Genetics, GSF-Research Center of Environment and Health, Munich Center for Integrated Protein Science (CiPSM), Marchioninistrasse 25, 81377 Munich, Germany.
Martin Heidemann
Thomas K Albert
Reinhard Mailhammer
Andrew Flatley
Michael Meisterernst
Elisabeth Kremmer
Dirk Eick

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA polymerase II is distinguished by its large carboxyl-terminal repeat domain (CTD), composed of repeats of the consensus heptapeptide Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7. Differential phosphorylation of serine-2 and serine-5 at the 5' and 3' regions of genes appears to coordinate the localization of transcription and RNA processing factors to the elongating polymerase complex. Using monoclonal antibodies, we reveal serine-7 phosphorylation on transcribed genes. This position does not appear to be phosphorylated in CTDs of less than 20 consensus repeats. The position of repeats where serine-7 is substituted influenced the appearance of distinct phosphorylated forms, suggesting functional differences between CTD regions. Our results indicate that restriction of serine-7 epitopes to the Linker-proximal region limits CTD phosphorylation patterns and is a requirement for optimal gene expression.

Indexed as

Gene Expression RegulationTranscription, GeneticAmino Acid SequenceAntibodies, MonoclonalCell Line, TumorChromatin ImmunoprecipitationEpitopesGenes, T-Cell Receptor betaHumansMolecular Sequence DataOligopeptidesPhosphorylationProtein SubunitsRNA Polymerase IISerineAntibodies, MonoclonalEpitopesOligopeptidesProtein SubunitsRNA Polymerase IISerine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.